References
Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W et al (2020) Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 383(27):2628–2638. https://doi.org/10.1056/NEJMoa2026834
Zakine E, Schell B, Battistella M, Vignon-Pennamen MD, Chasset F, Mahévas T et al (2021) UBA1 variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome. JAMA Dermatol. 157(11):1349–1354. https://doi.org/10.1001/jamadermatol.2021.3344
Huang H, Zhang W, Cai W, Liu J, Wang H, Qin T et al (2021) VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder. Exp Hematol Oncol. 10(1):23. https://doi.org/10.1186/s40164-021-00217-2
Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E et al (2022) French VEXAS group; GFEV, GFM, CEREMAIA, MINHEMON. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol. 186(3):564–574. https://doi.org/10.1111/bjd.20805
Grootjans J, Kaser A, Kaufman RJ, Blumberg RS (2016) The unfolded protein response in immunity and inflammation. Nat Rev Immunol. 16(8):469–484. https://doi.org/10.1038/nri.2016.62
Navid F, Colbert RA (2017) Causes and consequences of endoplasmic reticulum stress in rheumatic disease. Nat Rev Rheumatol. 13(1):25–40. https://doi.org/10.1038/nrrheum.2016.192
Ferrada M, Savic S, Alessi H, Ospina D, Wilson L, Goodspeed W et al (2021) Genotype and transfusion dependence predicts mortality in VEXAS syndrome, a newly described disease with overlap inflammatory and hematologic features [abstract]. Arthritis Rheumatol. 73 (suppl 10). https://acrabstracts.org/abstract/genotype-and-transfusion-dependence-predicts-mortality-in-vexas-syndrome-a-newly-described-disease-with-overlap-inflammatory-and-hematologic-features/. Accessed 16 April 2022
Mekinian A, Grignano E, Braun T, Decaux O, Liozon E, Costedoat-Chalumeau N et al (2016) Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology (Oxford). 55(2):291–300. https://doi.org/10.1093/rheumatology/kev294
Author information
Authors and Affiliations
Contributions
AN conceptualised and written initial draft. KPI, BB and CM involved in data curation, writing review and editing. All authors read, validated and authorised the final version of the manuscript.
Corresponding author
Ethics declarations
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nune, A., Iyengar, K.P., Barman, B. et al. The VEXAS syndrome from rheumatology perspective: genomic DNA sequencing as available blueprint for diagnosing rheumatic diseases with overlap** haematological or dermatological findings. Clin Rheumatol 41, 2917–2918 (2022). https://doi.org/10.1007/s10067-022-06211-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-022-06211-1